Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes

AIM: This post hoc analysis explored whether mealtime fast‐acting insulin aspart treatment provided an advantage in postprandial plasma glucose (PPG) control vs. insulin aspart in people with Type 2 diabetes receiving high doses of bolus insulin. METHODS: A post hoc, post‐randomization, subgroup ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowering, K., Harvey, J., Kolaczynski, J. W., Snyder, J. W., Bode, B. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588019/
https://www.ncbi.nlm.nih.gov/pubmed/30466191
http://dx.doi.org/10.1111/dme.13866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588019/
https://www.ncbi.nlm.nih.gov/pubmed/30466191
http://dx.doi.org/10.1111/dme.13866

Ejemplares similares